2017 is supposed to be the year that FDA finally approves a gene therapy. But last week, the company behind the first approved gene therapy in Europe, UniQure, announced that it won't “pursue the renewal of marketing authorization” that expires October 25.
What happened? Is the move a setback for gene therapies in the pipeline? I don’t think so.
Read More
What happened? Is the move a setback for gene therapies in the pipeline? I don’t think so.
Read More